Financial Information
SEC Filings
AMF Regulated Information
| Document | Year | Terms |
|---|---|---|
News • 01/12/2022 | Outstanding shares and voting rights statements Monthly information regarding the total number of voting rights and total number of shares of the Company as of December 31, 2021Download PDF | ||
News • 01/07/2022 DBV Technologies to Present at the H.C. Wainwright BioConnect 2022 ConferenceDownload PDF | ||
News • 12/20/2021 DBV Technologies Provides Update on Investigational Viaskin™ PeanutDownload PDF | ||
News • 12/10/2021 | Outstanding shares and voting rights statements Monthly information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2021Download PDF | ||
News • 11/24/2021 DBV Technologies to Participate in an Upcoming Investor ConferenceDownload PDF |
Annual Reports & General Meetings
| Document | Year | Terms |
|---|---|---|
News • 06/23/2021 | General Assembly AGM 2021 – Minutes of the Annual General MeetingDownload PDF | ||
News • 05/20/2021 | General Assembly AGM 2021 – Attendance sheetDownload PDF | ||
News • 05/20/2021 | General Assembly AGM 2021 – QuorumDownload PDF | ||
News • 05/20/2021 | General Assembly AGM 2021 – ResultsDownload PDF | ||
News • 05/19/2021 | General Assembly DBV Technologies Announces Results of its 2021 Ordinary and Extraordinary General Meeting and the Appointment of Dr. Adora Ndu, Pharm.D., J.D., and Dr. Ravi Madduri Rao, M.D., Ph.D., as Members of its Board of DirectorsDownload PDF |
PFIC Documents
